BACKGROUND: Corticobasal degeneration (CBD) is a neurodegenerative disease characterized pathologically by neuronal loss, gliosis and tau deposition in neocortex, basal ganglia and brainstem. Typical clinical presentation is known as corticobasal syndrome (CBS) and involves the core features of progressive asymmetric rigidity and apraxia, accompanied by other signs of cortical and extrapyramidal dysfunction. Asymmetry is also emphasized on neuroimaging. OBJECTIVE: To describe a series of cases of CBD with symmetric clinical features and to compare clinical and imaging features of these symmetric CBD cases (S-CBD) to typical cases of CBS with CBD pathology. METHODS: All cases of pathologically confirmed CBD from the Mayo Clinic Rochester database were identified. Clinical records were reviewed and quantitative volumetric analysis of symmetric atrophy on head MRI using atlas based parcellation was performed. Subjects were classified as S-CBD if no differences had been observed between right- and left-sided cortical or extrapyramidal signs or symptoms. S-CBD cases were compared to 10 randomly selected typical CBS cases. RESULTS: Five cases (2 female) met criteria for S-CBD. None had limb dystonia, myoclonus, apraxia or alien limb phenomena. S-CBD cases had significantly less asymmetric atrophy when compared with CBS cases (p=0.009); they were also younger at onset (median 61 versus 66 years, p<0.05) and death (67 versus 73 years, p<0.05). Family history was present in 40% of S-CBD cases. CONCLUSIONS: CBD can have a symmetric presentation, clinically and radiologically, in which typical features of CBS, such as limb apraxia, myoclonus, dystonia and alien limb phenomenon, may be absent. Copyright (c) 2009 Elsevier Ltd. All rights reserved.
BACKGROUND:Corticobasal degeneration (CBD) is a neurodegenerative disease characterized pathologically by neuronal loss, gliosis and tau deposition in neocortex, basal ganglia and brainstem. Typical clinical presentation is known as corticobasal syndrome (CBS) and involves the core features of progressive asymmetric rigidity and apraxia, accompanied by other signs of cortical and extrapyramidal dysfunction. Asymmetry is also emphasized on neuroimaging. OBJECTIVE: To describe a series of cases of CBD with symmetric clinical features and to compare clinical and imaging features of these symmetric CBD cases (S-CBD) to typical cases of CBS with CBD pathology. METHODS: All cases of pathologically confirmed CBD from the Mayo Clinic Rochester database were identified. Clinical records were reviewed and quantitative volumetric analysis of symmetric atrophy on head MRI using atlas based parcellation was performed. Subjects were classified as S-CBD if no differences had been observed between right- and left-sided cortical or extrapyramidal signs or symptoms. S-CBD cases were compared to 10 randomly selected typical CBS cases. RESULTS: Five cases (2 female) met criteria for S-CBD. None had limb dystonia, myoclonus, apraxia or alien limb phenomena. S-CBD cases had significantly less asymmetric atrophy when compared with CBS cases (p=0.009); they were also younger at onset (median 61 versus 66 years, p<0.05) and death (67 versus 73 years, p<0.05). Family history was present in 40% of S-CBD cases. CONCLUSIONS:CBD can have a symmetric presentation, clinically and radiologically, in which typical features of CBS, such as limb apraxia, myoclonus, dystonia and alien limb phenomenon, may be absent. Copyright (c) 2009 Elsevier Ltd. All rights reserved.
Authors: William T Hu; Gregory W Rippon; Bradley F Boeve; David S Knopman; Ronald C Petersen; Joseph E Parisi; Keith A Josephs Journal: Mov Disord Date: 2009-07-15 Impact factor: 10.338
Authors: I Litvan; Y Agid; C Goetz; J Jankovic; G K Wenning; J P Brandel; E C Lai; M Verny; K Ray-Chaudhuri; A McKee; K Jellinger; R K Pearce; J J Bartko Journal: Neurology Date: 1997-01 Impact factor: 9.910
Authors: Adam L Boxer; Michael D Geschwind; Nataliya Belfor; Maria Luisa Gorno-Tempini; Guido F Schauer; Bruce L Miller; Michael W Weiner; Howard J Rosen Journal: Arch Neurol Date: 2006-01
Authors: B F Boeve; D M Maraganore; J E Parisi; J E Ahlskog; N Graff-Radford; R J Caselli; D W Dickson; E Kokmen; R C Petersen Journal: Neurology Date: 1999-09-11 Impact factor: 9.910
Authors: Keith A Josephs; Joseph R Duffy; Edyth A Strand; Jennifer L Whitwell; Kenneth F Layton; Joseph E Parisi; Mary F Hauser; Robert J Witte; Bradley F Boeve; David S Knopman; Dennis W Dickson; Clifford R Jack; Ronald C Petersen Journal: Brain Date: 2006-04-13 Impact factor: 13.501
Authors: Naomi Kouri; Melissa E Murray; Anhar Hassan; Rosa Rademakers; Ryan J Uitti; Bradley F Boeve; Neill R Graff-Radford; Zbigniew K Wszolek; Irene Litvan; Keith A Josephs; Dennis W Dickson Journal: Brain Date: 2011-09-20 Impact factor: 13.501
Authors: Jennifer L Whitwell; Jia Xu; Jay Mandrekar; Bradley F Boeve; David S Knopman; Joseph E Parisi; Matthew L Senjem; Dennis W Dickson; Ronald C Petersen; Rosa Rademakers; Clifford R Jack; Keith A Josephs Journal: Neurobiol Aging Date: 2012-04-11 Impact factor: 4.673
Authors: J L Whitwell; C R Jack; B F Boeve; J E Parisi; J E Ahlskog; D A Drubach; M L Senjem; D S Knopman; R C Petersen; D W Dickson; K A Josephs Journal: Neurology Date: 2010-11-23 Impact factor: 9.910
Authors: Suzee E Lee; Gil D Rabinovici; Mary Catherine Mayo; Stephen M Wilson; William W Seeley; Stephen J DeArmond; Eric J Huang; John Q Trojanowski; Matthew E Growdon; Jung Y Jang; Manu Sidhu; Tricia M See; Anna M Karydas; Maria-Luisa Gorno-Tempini; Adam L Boxer; Michael W Weiner; Michael D Geschwind; Katherine P Rankin; Bruce L Miller Journal: Ann Neurol Date: 2011-08 Impact factor: 10.422
Authors: Naomi Kouri; Jennifer L Whitwell; Keith A Josephs; Rosa Rademakers; Dennis W Dickson Journal: Nat Rev Neurol Date: 2011-04-12 Impact factor: 42.937
Authors: Naomi Kouri; Kenichi Oshima; Makio Takahashi; Melissa E Murray; Zeshan Ahmed; Joseph E Parisi; Shu-Hui C Yen; Dennis W Dickson Journal: Acta Neuropathol Date: 2013-01-31 Impact factor: 17.088